Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-22-014695

Chief Financial Officer bought 39,000 shares at an average $0.29 ($11,161)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hunt Jonathan Robert Chief Financial Officer 2022-06-07 Purchase +13,325 $0.28 $3,718 80,631 D
Hunt Jonathan Robert Chief Financial Officer 2022-06-08 Purchase +25,675 $0.29 $7,443 106,306 D
Open-market purchases · 39,000 sh · avg $0.29 · $11,161
Loading xslF345X03/rdgdoc.xml…